| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.24 | 5e-13 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-12 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-08 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-07 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-07 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.15 | 9e-07 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.13 | 1e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |